[Elsevier] Efficacy and safety of obinutuzumab 汕 in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

11235 Post time 12 min. ago | Show all posts |Read mode
This post will be closed automatically in 2026-11-22 16:07
Reward10points

Efficacy and safety of obinutuzumab 汕 in patients with active systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialDOIㄩ10.1016/S2665-9913(26)00315-2
The Lancet Rheumatology
       
https://doi.org/10.1016/S2665-9913(26)00315-2



Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    1930


Return to the list